True lab orchestration isn't about coordinating instruments, it's about connecting scientific intent, data, and decisions ...
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, explains why the full ...
In today's ACT Brief, we examine genuine patient partnership in trial design, how AI enables informed recruitment while ...
In today's ACT Brief, we examine why black-box AI fails in clinical trials, how participant understanding drives engagement ...
In this Q&A, Patrick Mizer, chief technology officer at Ledger Run, discusses how payment reliability has become a ...
Senior leaders reiterated that GCP expectations are geography-agnostic, and inadequate inspection access can render foreign ...
In this Q&A, John Worden, chief commercial officer at Javara, discusses why clinical trial recruitment has remained stubbornly one-size-fits-all, how AI can identify patients at scale without ...
In today's ACT Brief, we examine value hidden in the RBQM financial model, why rare disease research leads on genuine patient ...
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD discuss what the RBQM financial ...
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain how combining real-world ...
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain why time savings dominates ...
Agentic AI is arriving in clinical operations with genuine capability to absorb administrative work, but the organizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results